# A Study in Healthy Volunteers to Compare Different Tablet Formulations of the Test Medicine, GLPG1972, Against the Current Tablet Formulation, and to Assess the Effect Food Has on One of the Test Medicines

> **NCT04137341** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG1972 - A
- **DRUG:** GLPG1972 - B
- **DRUG:** GLPG1972 - C

## Key facts

- **NCT ID:** NCT04137341
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-09
- **Primary completion:** 2019-12-13
- **Final completion:** 2019-12-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137341, "A Study in Healthy Volunteers to Compare Different Tablet Formulations of the Test Medicine, GLPG1972, Against the Current Tablet Formulation, and to Assess the Effect Food Has on One of the Test Medicines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04137341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*